CHU de Nice
Nice, 06003, France
NCT Number: NCT00888966
Cardiac arrest is a major health problem reaching 375000 cases in Europe each year. Only 5 to 31 % survive after an out of hospital cardiac arrest (OHCA). The main complication after OHCA is the anoxic encephalopathy. Recently mild hypothermia has shown a beneficial effect on survival. But the mechanisms underlying these therapy are not clear.
Cardiac arrest is an example of ischemia reperfusion of the entire body. And it is well demonstrated that reperfusion generates an oxidative stress. But it has never been shown in a clinical setting.
The aim of the study is to evaluate oxidative stress after out of hospital cardiac arrest treated with mild hypothermia.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Nice, 06003, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 4 days
Time frame: 4 days
Time frame: 6 months
Institut d'Anesthesiologie des Alpes Maritimes
Other
Evaluation of Oxidative Stress After Out of Hospital Cardiac Arrest Treated With Moderate Hypothermia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02007499
Cardiac Arrest, Cardiopulmonary Arrest
Milwaukee, Wisconsin, United States
View Trial DetailsNCT02555254
Body Temperature Changes, Cardiac Arrest
La Roche-sur-Yon, France
View Trial DetailsNCT05646875
Brain Diseases, Brain Injuries
Edegem, Belgium
View Trial DetailsNCT05316779
Anesthesia, Cardiovascular Diseases
Bern, Switzerland
View Trial Details